The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
This has a long way to run, in normal circumstances that would sound silly about a SP that has risen 40x, but firstly its about mcap, its not hight, and this is one of those very very rare circumstances where the right company meet the right time and the right (unfortunate) circumstance. This is often how companies begin greatness. People laughed at ASOS, which ended up doing 1000x, it entered the right market (internet shopping) at the right time. NCYT is like ASOS on steroids, as because of the times we find ourselves in, everything is fast forwarded, companies that may take years to make these gains are hyper speeded as because the need is so great. Just hold is my advice, wait for 400m-500m mcap. Then reassess.
So funny, people still don't just get it do they, some said 60p was too much, 9inch and codey thought 100p was too much, then 1.50 was too much. Questioning what NCYT have - well what they have is the golden goose PCR test are in bed with the majors, have raw materials last checked two weeks ago for 18m tests. The world wants tests desperately and they have distributors to 80+ countries. Demand is off the scale and they are one of 2 only recognised by the WHO - the best of the best. They sold warrants for millions months ago, already are receiving ton's of cash, and are massively increasing capacity.
All these other tests that are being mentioned are being developed and are 1-2 months away from even being ready - then what accuracy will they have. They may do very well, but significant news for them is in the future. Where will NCYT be by then in 1-2 months, with proven science, huge orders and working with the 2 biggest pharma companies in the UK.
There will be only one NCYT - its great that companies such as ODX and others are all finding new ways to fight this terrible pandemic, hats off to them all. NCYT has though first mover advantage and is now a heck of a lot less risky now - we know the science works, we know they have great management and team, we know they have distributors to over 80+ countries, we know they are working with the biggest of boys. These new plays are like early days NCYT - some may make it, but to be as good as NCYT they have to tick all those boxes we've already ticked. Good luck and hope it works well, as there is a very large pie out there and we need all the help we can get.
NCYT have just been endorsed by the WHO, and by the government to work with GSK and Astra to form the pillar of testing for this country and beyond. Its been rubber stamped by the biggest and brightest to be a success, all you have to do as a shareholder is sit back and relax knowing that this company is going places.
https://twitter.com/Peston/status/1247779918097735686
Peston says
"I have been bemused by why government was not working closer with Novacyt and never got satisfactory answers. But this looks like a big deal"
Those saying sell the news - well which news, there is normally 2-4 RNS's a week, each one growing the story, growing the reputation, growing the sales, growing the demand. If people listened to these people most would have sold out at 70p, or £1, or £1.50...This is a unique share in a unique situation - the mcap is still cheap for the recognition and brilliant product in a situation where demand all over the world is huge.
Forget that, all you need to know is Testing has become the big thing for this country and every country. I will say it again DEMAND > SUPPLY, that is all you need to know and understand. Let me say it again DEMAND is massively and I MEAN massively outstripping SUPPLY. Simple economics. No matter it every diagnostic kit no matter how bad (ours is great BTW) produced at full capacity they can't meet SUPPLY. It is why so many countries desperately bought dodgy crappy stock from China. COUNTRIES are DESPERATE. Sorry for the capitals, but I'm just trying to point out the obvious to the deluded. NCYT has one of the best test kits out there. They will sell every kit they make and people will still be begging for more. Simples, the price is still cheap.
Just for a moment the derampers are silent....But they'll be back they just know that now is not the time, they wait for that moment of doubt when their fud may shake you out. Don't, hold strong, as I said from the beginning this will be a mid-tier pharma company in the making - so with that I expect 400-500m mcap, i.e 3-4x current sp price. Obviously things may change for the + or - by circumstances or judgements made by the company, but at the moment in time on this trajectory I really think that is a possibility in the coming weeks.
Was asked on GMTV out of the 100,000 test's a day what proportion would be antibody and what proportion would be our antigen test. He said at the moment there is no antibody test that works, so at this moment he expects all those 100k tests to be with the old pcr test method but obviously hopes antibody tests by the end will play a part. Also mentioned they had rejected many tests due to their inaccuracy. NCYT says "hold my beer"
Ghia the only thing laughable is your claim to be an investor, your not, period, full stop. Classic deramping 101 textbook, claim to hold a stake, and continuously point holes in it. Its so obvious its off the scale, stop, your embarrassing yourself.
And now the derampers go quiet, praying, hoping there is no RNS in the morning so they can continue their diatribe. It doesn't matter if its tomorrow morning if there is no RNS, the pressure will build, and so far NCYT every step, every hurdle have delivered, and IMHO will deliver again. It's lovely knowing a great RNS is coming in the next couple of days, it makes their efforts so much harder and desperate, in AIM they normally get it so easy, but in this unfortunate pandemic situation their time is limited, see you on the other side.